The California-based pharmaceutical company, founded in 2015, focuses on developing novel molecules that specifically target aggressive cancer cells. These cells over-express unique amino acid transporters on their surfaces to support rapid tumor growth. By exploiting this biology, Quadriga aims to provide safer and more effective treatments for cancer patients.